The journal brings readers the latest developments in the fast moving field of cellular therapy in man. This includes cell therapy for cancer, immune disorders, inherited diseases, tissue repair and regenerative medicine. The journal covers the science, translational development and treatment with variety of cell types including hematopoietic stem cells, immune cells (dendritic cells, NK, cells, T cells, antigen presenting cells) mesenchymal stromal cells, adipose cells, nerve, muscle, vascular and endothelial cells, and induced pluripotential stem cells. We also welcome manuscripts on subcellular derivatives such as exosomes. A specific focus is on translational research that brings cell therapy to the clinic. Cytotherapy publishes original papers, reviews, position papers editorials, commentaries and letters to the editor. We welcome "Protocols in Cytotherapy" bringing standard operating procedure for production specific cell types for clinical use within the reach of the readership.
《Cytotherapy》是一本由ELSEVIER SCI LTD出版商出版的專業醫學期刊，該刊創刊于1999年，刊期Bimonthly，該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：醫學 2區，小類學科：生物工程與應用微生物 2區；細胞與組織工程 3區；細胞生物學 3區；血液學 3區；醫學：研究與實驗 3區；在JCR（Journal Citation Reports）分區等級為Q1。該刊發文范圍涵蓋生物工程與應用微生物等領域，旨在及時、準確、全面地報道國內外生物工程與應用微生物工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為6.196，平均審稿速度偏慢,4-8周。
| 大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
| 醫學 | 3區 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程與應用微生物 CELL & TISSUE ENGINEERING 細胞與組織工程 HEMATOLOGY 血液學 MEDICINE, RESEARCH & EXPERIMENTAL 醫學：研究與實驗 CELL BIOLOGY 細胞生物學 | 3區 3區 3區 3區 4區 | 否 | 否 |
| JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
| Q1 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | Q1 | 6.196 |
| HEMATOLOGY | Q2 | ||
| CELL BIOLOGY | Q2 | ||
| CELL & TISSUE ENGINEERING | Q2 | ||
| MEDICINE, RESEARCH & EXPERIMENTAL | Q2 |
| 影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
| 6.196 | 76 | 18.69% | 84.92% | 未開放 | 偏慢,4-8周 |
投稿咨詢
課題、SCI/EI/SSCI怎么寫？